Global Phase I Network START operates a global network of Phase I cancer trial sites in San Antonio, Madrid, and Shanghai, presenting a potential for cross-border collaboration and multi-site trial opportunities for sponsors seeking diverse geographies and accelerated enrollment.

Cancer Focused Expertise With a mission to accelerate anticancer drug development and a team of highly trained physicians experienced in Phase I research, START can position itself as a specialized partner for early-stage oncology programs and first-in-human studies.

Speed and Access The 24/7 global site model is designed to keep drug development running continuously, offering faster enrollment and study progression for sponsors aiming to shorten development timelines and improve patient access to novel therapies.

Mid-Sized SYnergies As a smaller organization with global reach, START can complement larger centers by handling specialized Phase I execution, site coordination, and accelerated data collection, appealing to sponsors seeking agile, cost-conscious early-phase partnerships.

fisc ally Potential Revenue in the low to mid single digits indicates a growth ceiling but also suggests potential for expanded services, additional trials, and tiered partnerships; sales conversations can explore expanded trial portfolios, global site expansions, and value-added services like patient recruitment optimization and digital trial tools.